Related Experiment Video
Updated: Jun 20, 2026

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
Published on: September 5, 2017
Epidemiology of extrapulmonary tuberculosis, Alameda County, California, 2010-2021
Saliha Nasir1, Rachel Marusinec1, Amit S Chitnis1
1Tuberculosis Section, Division of Communicable Disease Control and Prevention, Alameda County Health, Public Health Department, 1100 San Leandro Blvd, San Leandro, CA 94577, USA.
Background:
Extrapulmonary tuberculosis (EPTB) represents a range of disease manifestations, and is a major contributor to ongoing TB burden in the United States. We examined the incidence, trends and characteristics of EPTB in a high-burden TB county in Northern California.
Methods:
We extracted surveillance data for all TB cases in Alameda County during 2010-2021. TB was classified per national surveillance definitions, and EPTB included any site involvement other than the lung. We determined overall and annual incidence of EPTB in comparison to pulmonary TB (PTB), and assessed trends in incidence using Poisson regression and proportion with Joinpoint regression. We further compared clinical and demographic characteristics by TB site of disease.
Results:
Of 1,336 TB cases included, 372 (28%) had EPTB disease only. Lymph nodes were the most common site (38.7%), followed by pleura (17.7%), peritoneal (5.4%), and bone (4.8%). From 2010 to 2021, EPTB incidence decreased by 52% from 3.5 to 1.7 cases per 100,000. However, the proportion of TB cases that were extrapulmonary increased from 2015 to 2021 (8.3% annual change, 95% CI 5.2%-14.2%). In comparison to PTB, EPTB case-patients were more likely to be aged < 45 years old, have end-stage renal disease, and pyrazinamide monoresistance, but less likely to have microbiological confirmation.
Conclusions:
EPTB incidence has decreased over time, but the proportion of EPTB cases increased. Greater awareness of clinical and demographic characteristics of EPTB may guide targeted interventions to support TB elimination.
Related Concept Videos
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Tuberculosis
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
